Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
By Xinyang Hu, S. Yu, Jamie L. Fraser, Zhongyang Lu, M. Ogle, Jian-an Wang, Ling Wei. Journal of Thoracic and Cardiovascular Surgery, 2008
621 citations recorded by the source corpus.
Subfields: Genetics, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/49c116ec00fa79fb1efd64b1440df7a427f9bbfa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yin Xiao
- Liping Zhang
- Yinghong Zhou
- Mengchi Xu
- Hepeng Yu
- Ying Min
- Xi Wang
- Li Duan
Citations in the corpus
- Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. (2013, background): “Being an oxygen sensor, HIF-1a protein is stabilized in hypoxia [45], and involves in the activation of VEGF, among other genes, which is associated with neovascularization and tissue regeneration [46].”
- Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model (2013, background): “It is postulated that HIFs might play a critical role in the proangiogenesis of MSC-EVs produced under different conditions [30, 31, 49, 50].”